Rubius Therapeutics (NASDAQ:RUBY) stock is heading higher on Tuesday despite a lack of news from the cellular medicines company. Instead, it looks like increasing interest from traders is behind today ...
CHICAGO, July 8 (Reuters) - U.S. casual dining chain Ruby Tuesday Inc posted quarterly earnings that beat analysts' expectations as new menu items like lobster tails and advertising focused at local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results